Abstract

Biological Copper oxide nanoparticles (CuO-NPs) were produced utilizing biomass extract of two endophytic actinomycetes isolates, Streptomyces noursei (A-1) and Streptomyces fradiae (A-2). The molecular identification of these two actinomycetes species was accomplished using 16S RNA sequence analysis. UV-Visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, and transmission electron microscopy (TEM) were utilized to characterize these biological CuO-NPs. The surface Plasmon resonance (SPR) absorption band of biologically synthesized CuO-NPs was in the spectrum of 410 to 450 nm. These NPs were spherical and crystalline in morphology, with a mean range of 50 to 100 nm. XRD analysis was employed to investigate the crystallinity of these NPs. Different bonds, such as C-O and N-H bonds, were identified in these NPs, as revealed by FTIR spectra. When it came to medicinal applications, the biosynthesized CuO-NPs were remarkably efficacious. The biologically synthesized CuO Nanoparticles (A-1 and A-2) shows the good Scavenging activity which indicated that biologically synthesized CuO Nanoparticles (A-1 and A-2) has an antioxidant property. Prepared biosynthesized Cu oxide nanoparticles are biologically active and will becomes a foundation in the different field of biotechnological applications including environmental, industrial, medical etc.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.